So cerebral edema in ischemic stroke is part of the natural history, and it can be fatal. It has a high mortality. Most of the time, we know that reperfusion in a timely manner will reduce cerebral edema. However, there’s particular concerns that if someone presents at baseline with a large core already, that you reperfuse the core, it would actually exacerbate the edema. And that originates from earlier animal studies that show that if you have transient MCA occlusion, the cerebral edema actually increases and there’s larger infarct as well...
So cerebral edema in ischemic stroke is part of the natural history, and it can be fatal. It has a high mortality. Most of the time, we know that reperfusion in a timely manner will reduce cerebral edema. However, there’s particular concerns that if someone presents at baseline with a large core already, that you reperfuse the core, it would actually exacerbate the edema. And that originates from earlier animal studies that show that if you have transient MCA occlusion, the cerebral edema actually increases and there’s larger infarct as well. So the particular concerns, of course, is if someone comes in who has large core already, the clinical guidelines at the moment and the evidence supports that we should be doing thrombectomy. However, a portion of such patients will be more susceptible to developing cerebral edema. So the SELECT2 trial is a large-core trial that looked at whether thrombectomy compared to standard care for patients presenting with a large-core defined by ASPECTS 3 to 5 or at least a core volume of 50, whether thrombectomy would be beneficial. It was a positive trial that showed thrombectomy is associated with better functional outcome in such large core patients. We performed a secondary analysis focusing on edema development in these patients. And what we found that was that cerebral edema was higher in the thrombectomy cohort. So that means patients who had thrombectomy of a large core are more prone to cerebral edema. It would reduce slightly the benefits of thrombectomy. However, that doesn’t necessarily mean that we should withhold thrombectomy because overall on a population level, at a group study level, patients who have large core still derive benefits from thrombectomy even though there was a higher chance of cerebral edema developing. And what the secondary analysis conveys is that when we do thrombectomy on large-core patients, we should be more careful about cerebral edema developing in patients, and we should make preparatory steps. So, for example, we should talk in advance with the patient when they consent that this might be happening so that they have an informed consent, informed opinion when they decide on whether to have thrombectomy or not or have any other treatment. And once thrombectomy has occurred, then there should be more intense monitoring. That might be the form of an early CT that looks at whether there’s evolving edema several hours after thrombectomy and follow such patients on with more frequent serial CT so that if there’s early signs of edema, we are all ready to perform salvage or any treatment procedures such as decompressive craniotomy. And that also would mean a more frequent clinical monitoring, probably up to the first three to five days.
This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.